Oxidative stress and its relationship with adenosine deaminase activity in various stages of breast cancer

被引:31
作者
Mahajan M. [1 ]
Tiwari N. [1 ]
Sharma R. [1 ]
Kaur S. [1 ]
Singh N. [2 ]
机构
[1] Department of Biochemistry, Government Medical College, Amritsar, Punjab
[2] Department of Surgery, Guru Nanak Dev Hospital Amritsar, Amritsar
关键词
Adenosine deaminase; Breast cancer; GSH; SOD;
D O I
10.1007/s12291-012-0244-5
中图分类号
学科分类号
摘要
Reactive oxygen species (ROS) cause damage to the DNA producing mutations and formation of tumours such as carcinoma of breast. Tumour cells are known to produce ROS at a greater pace than the non-transformed cells. The increased production of reactive oxygen species causes oxidative stress leading to cell proliferation and hence increased inflammatory conditions. The present study was aimed to investigate the role of oxidative stress in the pathogenesis of breast cancer. Females suffering from breast cancer had significantly decreased Superoxide dismutase (SOD) and reduced glutathione (GSH) levels in comparison to normal females. The compromised antioxidant defence system produces the oxidative stress which in turn creates the inflammatory response shown by concomitant increased adenosine deaminase (ADA) activity in female patients. ADA diminishes the protective molecule adenosine. There were significant variations (p < 0.01) in ADA activity with different clinical stages (stage 1-4) of breast cancer suggesting thereby that estimation of ADA activity can be used as a diagnostic tool to detect the stage of cancer along with cytological studies. Mastectomy was performed and post-operatively serum SOD and ADA activity and plasma GSH levels were estimated. There was a statistically significant increase in activity of SOD and levels of GSH while serum ADA activity decreased significantly, suggesting thereby that oxidative stress is responsible for increased cell proliferation and hence the inflammatory conditions in CA breast that got ameliorated post-operatively. © 2012 Association of Clinical Biochemists of India.
引用
收藏
页码:51 / 54
页数:3
相关论文
共 21 条
[1]  
Guyton K.Z., Kensler T.M., Oxidative mechanisms in carcinogenesis, Br Med Bull., 49, 3, pp. 523-544, (1993)
[2]  
Mealiffe M.E., Stokowski R.P., Rhees B.K., Prentice R.L., Pettinger M., Hinds D.A., Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information, J Natl Cancer Inst., 102, pp. 1618-1627, (2010)
[3]  
Benson J.R., Jatoi I., Keisch M., Esteva F.J., Makris A., Jordan V.C., Early breast cancer, Lancet., 373, 9673, pp. 1463-1479, (2009)
[4]  
Saslow D., Boetes C., Burke W., Harms S., Leach M.O., Lehman C.D., Et al., American cancer society guidelines for breast screening with MRI as an adjunct to mammography, CA Cancer J Clin., 57, pp. 75-89, (2007)
[5]  
Guray M., Sahin A.A., Beningn breast diseases: C Breast disorders: Introduction. Merck manual of diagnosis and classification, diagnosis and management, Oncologist., 11, pp. 435-449, (2006)
[6]  
Seth R.K., Kharb S., Kharb D.P., Serum biochemical markers in carcinoma breast, Indian J Med Sci., 57, 8, pp. 350-354, (2003)
[7]  
Negahdar M., Abtahi H., Sadeghi M.R., Javadi E., Aghvani T., Layegh H., Blood superoxide dismutase and catalase activities in women affected with breast cancer, Iran J Public Health., 34, pp. 39-43, (2005)
[8]  
Sharma P., Sharma D.C., Mishra S., Studies of biochemical parameters in breast cancer with and without metastasis, Indian J Clin Biochem., 19, 1, pp. 71-75, (2004)
[9]  
Perquin M., Oster T., Maul A., Froment N., Bagrel D., The glutathione related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features, J Can Res Clin Oncol., 127, 6, pp. 368-374, (2001)
[10]  
Aboughalia A.H., Fouad I.M., Glutathione and its metabolizing enzymes in patients with different benign and malignant disease, Clin Biochem., 33, 8, pp. 657-662, (2000)